Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder
Jose Martinez-Raga,1,2 Carlos Knecht,3 Raquel de Alvaro4 1Teaching Unit of Psychiatry and Psychological Medicine, University Hospital Doctor Peset, University of Valencia, 2CEU Cardenal Herrera University, 3Área de Salud Mental, Hospital Padre Jofré, Valencia, 4Hospital Genera...
Main Authors: | Martinez-Raga J, Knecht C, de Alvaro R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-05-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/profile-of-guanfacine-extended-release-and-its-potential-in-the-treatm-peer-reviewed-article-NDT |
Similar Items
-
Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study
by: Akira Iwanami, et al.
Published: (2020-12-01) -
An adolescent boy with kleptomania and attention‐deficit hyperactivity disorder treated with methylphenidate and guanfacine: A case report
by: Kensuke Miyazaki, et al.
Published: (2023-12-01) -
A retrospective medical chart review of clinical outcomes in children and adolescents with attention-deficit/hyperactivity disorder treated with guanfacine extended-release in routine Canadian clinical practice
by: Judy van Stralen, et al.
Published: (2021-10-01) -
Efficacy and safety of guanfacine extended‐release in Japanese adults with attention‐deficit/hyperactivity disorder: Exploratory post hoc subgroup analyses of a randomized, double‐blind, placebo‐controlled study
by: Noriyuki Naya, et al.
Published: (2021-03-01) -
The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD)
by: Sagvolden Terje
Published: (2006-12-01)